« During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the MPN Hub spoke to the Steering Committee Chair, Jean-Jacques Kiladjian, Université de Paris, Paris, FR. We asked, When can we safely discontinue interferon alpha therapy in patients with myeloproliferative neoplasms? »
When can we safely discontinue Pegasys in patien... - MPN Voice
When can we safely discontinue Pegasys in patients with MPN?
Written by
Manouche
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
3rd dose COVID vaccination for MPN patients
clinician community advising MPN Voice have discussed and agreed that patients with MPN of any...
Video of the MPN Voice ‘Virtual’ Patients’ Forum – Manchester
people with MPNs.
The forum is chaired by Jon Mathias, Co-Chair MPN Voice.
The breakout groups...
CHANGE OF DATE for the webinar for MPN patients relating to government guidance on COVID-19
CHANGE OF DATE for the Webinar for MPN patients relating to government guidance on......
Three MPN Voice Patients’ Forums confirmed
are very pleased to announce details for 3 MPN Voice patients’ forums in Manchester, Llandudno and...
UPDATE TO OUR ADVICE RE: 3rd dose COVID vaccination for MPN patients
links below:
MPN Voice letter http://www.mpnvoice.org.uk/wp-content/uploads/2021/09/MPN-Voice_3rd_do
ASH paper re younger MPN patients, dx age <= 40
Pegasys is applying for formal approval in MPN treatment
UPDATE: Would You Like to Have a Patient Led MPN Support Group in Devon and Cornwall?
